Post Report: 8th Annual Pharma Project and Portfolio Management 2025

8th Annual Pharma Project and Portfolio Management 2025

 
January 22-24, 2025 | Hilton Goa Resort

The 8th Annual Pharma Project & Portfolio Management 2025 was a remarkable success, uniting leaders from pharmaceutical portfolio, project, and regulatory affairs. Centered around the theme "Waves of Wisdom – Decisions Inspired by Intelligence, Implemented by Artificial Intelligence," the event provided a platform for professionals to refine their expertise in the rapidly evolving pharma landscape.

Over three dynamic days, attendees gained cutting-edge insights, explored practical strategies, and engaged in high-impact networking with industry experts driving the future of project and portfolio management.

Event Success and Key Highlights
The event began with an inspiring welcome address by Ms. Guneet Kaur Hayer, Managing Director of Eminence Group, creating an atmosphere of enthusiasm and learning. As the program unfolded, expert-led sessions explored the indispensable role of collaboration and innovation in shaping the future of project and portfolio management.

Revitalizing Pharma Product Pipelines: Strategies for Addressing the Dry Pipeline Issue
Dr. Janani Swaminathan from Bharat Serums & Vaccines Limited provided an in-depth analysis of the challenges faced by pharmaceutical companies due to stagnant product pipelines. She highlighted innovative strategies for revitalizing product development, and optimizing R&D investments. Her 15-minute presentation was followed by an expert panel discussion featuring Mr. Mike Teiler from Teiler Group and Mr. John Robert from Moonshoot Systems. The panel experts shared insights on overcoming hurdles, enhancing collaboration between R&D and business teams, and accelerating time-to-market for new therapies.
 
Navigating Global Regulatory Guidelines: Insights on FDA and EMA Submissions
Ms. Meenakshi Jain from Sandoz delivered a comprehensive session on navigating the complex regulatory frameworks governing drug approvals, particularly focusing on FDA submissions for generics and the 505(b)(2) pathway. She elaborated on the intricacies of dossier preparation, bioequivalence requirements, and global intellectual property considerations. The session also scored how to enhance regulatory intelligence to improve approval timelines for pharmaceutical companies.

Sharpening Decision-Making Skills: Tackling Challenges in Pharma
Mr. Dheeraj Salian from Eminence Group conducted an interactive game session designed to enhance decision-making capabilities among pharma professionals. Participants engaged in real-world problem-solving exercises aimed at refining strategic thinking, stakeholder management, teamwork, and financial decision-making. By simulating complex scenarios, the session encouraged participants to adopt structured approaches to resolving industry challenges while balancing business objectives and patient needs.

Streamlining Collaboration in Pharma: Leveraging Technology for Seamless CFT
Mr. Girish Kulkarni from Strides highlighted the role of digital transformation in improving collaboration across pharmaceutical product development teams. He demonstrated how centralized project management tools, real-time dashboards, and AI-driven analytics create a single source of truth for tracking product launches, ensuring transparency, efficiency, and better governance.
 
Simplifying Complex Decisions in Pharma Portfolios
Mr. Mike Teiler from Teiler Group provided an in-depth look at best practices for evaluating potential product acquisitions. The session covered risk assessment frameworks, financial modelling techniques, and integration strategies to help companies make informed portfolio decisions. He emphasized the importance of leveraging data-driven insights and rapid scenario analysis for accelerating decision-making in competitive markets.

Navigating Regulatory Changes: The Bio-Secure Act's Global Impact
Dr. Bobby George from Reliance Life Sciences dissected the Bio-Secure Act and its far-reaching implications on the pharmaceutical and biotech industries. His discussion centered on compliance mandates, potential supply chain disruptions, and export restrictions that could affect global market access. He also explored proactive strategies for mitigating risks and ensuring business continuity amid evolving regulatory landscapes.
 
Clinical Considerations in Portfolio Selection: A Key to Patient-Centric Development
Mr. Nirav Jansari from Sandoz Pvt. Ltd. explored the critical role of clinical factors in shaping pharmaceutical portfolio decisions. His session delved into the impact of dosage forms, delivery mechanisms, and patient adherence on drug development strategies. Attendees gained insights into how these considerations influence budgeting, regulatory approvals, and long-term market viability.

Maximizing Time Efficiency in Indian Pharma: Data-Driven Insights
Ms. Guneet Kaur Hayer from Eminence Group shared practical strategies for enhancing productivity. Using case studies and real-world applications, she demonstrated how daily performance analysis can optimize workflow prioritization, minimize bottlenecks, and improve time management across departments.
 
Global Development of Biosimilars: Key Strategies for Project & Program Management
Mr. Sivanandam Kesavan from Biocon Biologics presented a comprehensive roadmap for successfully launching biosimilars in international markets. He provided insights into global regulatory trends, the evolving biosimilar landscape, and strategic partnerships that can accelerate development timelines while ensuring compliance with market-specific requirements.
 
AI's Role in Pharma: Harnessing Smart Adoption with Live Case Scenarios
Mr. Aniruddh Galgaly from Cipla showcased how artificial intelligence is revolutionizing pharmaceutical research, development, and operations. By presenting live case scenarios, he illustrated AI's applications in drug discovery, predictive analytics, and real-time decision-making, making a compelling case for its strategic adoption.
 
Mastering Stakeholder Management: Communication & Soft Skills for Project Success
Mr. Jayesh Khatri from Ashish Lifesciences Pvt. Ltd. emphasized the importance of effective communication and soft skills in managing complex pharma projects. He provided actionable techniques for navigating stakeholder expectations, fostering cross-functional collaboration, and ensuring seamless execution of project goals.
 
Exploring Pharma Portfolio Feasibility in Emerging Markets
Mr. Sanjay Bhanushali from Heramb Consulting led an insightful session on the challenges and opportunities of entering emerging markets. Using real-world case studies, he guided participants in exploring economic, regulatory, and cultural factors that influence portfolio expansion, while also discussing strategies to mitigate risks and maximize market potential.
 
Transforming Pharma Project & Portfolio: Leveraging Technology for Enhanced Decision Making
Mr. Vishnu Prasad from Asana opened the session with insightful real-world case scenarios, setting the stage for an in-depth discussion. Later, Mr. Sandeep Koul from Wockhardt and Mr. Jayesh Khatri from Ashish Lifesciences Pvt. Ltd. reviewed cutting-edge digital tools designed to enhance project and portfolio management in pharma. The session featured interactive demonstrations of AI-powered decision-support systems and advanced data visualization techniques.

Building Resilience: Bulletproof Project Management with Self-Management Skills.
Mr. John Robert from Moonshot Systems equipped pharma professionals with essential self-management strategies to effectively handle stress, embrace project challenges, and maintain a healthy work-life balance. His session emphasized building resilience and sustaining motivation in high-pressure environments.

The Great Project Management Race: Competing Methodologies in Action
Mr. Navtej Singh from Accelero Consultings led an engaging session comparing various project management methodologies. Through practical exercises, he demonstrated how frameworks like Agile, Waterfall, CPM, and CCPM can be effectively applied to optimize pharma project execution. The session concluded with insights from Mr. Mike Teiler, who shared key takeaways on adapting methodologies to business needs.
 
Building a Knowledge Legacy: Retaining Insights After Project Closure
Mr. Abhishek Mittal from Neuland Labs introduced best practices for preserving project knowledge and institutional memory. He discussed strategies for documenting key learnings, creating knowledge repositories, and implementing systematic handover processes to ensure continuity in pharma project management.

Revolutionizing Pharma Operations through Integrated Collaboration and AI
Mr. Nikhilesh Garnepudy from PlanView explained how AI-driven collaboration platforms enhance operational efficiency in pharma. His session highlighted their role in improving project prioritization, regulatory compliance tracking, and resource allocation to maximize return on investment.
 
Empowering Project Managers in Matrix Organizations: Leadership and Collaboration
Mr. Debasish Mitra from Cipla shared leadership strategies tailored for project managers in matrix organizations. He explained the significance of aligning team objectives, fostering interdepartmental collaboration, and building a shared vision to drive project success.
 
Revolutionizing Project Management: Insights from Real-World Technology Applications
Mr. Sandeep Koul from Wockhardt demonstrated how real-world technology applications are transforming pharma project management. His session featured case studies on streamlining workflows, automating processes, and enhancing decision-making through digital solutions.

The Future of Pharma Project Management: Evolving Methodologies and Technology
Mr. Abhay Rahangdale from Alkem Laboratories provided a forward-looking perspective on the evolution of project management in the pharma sector. He explored emerging methodologies, the integration of advanced digital tools, and the evolving skill sets required to navigate the industry's future challenges successfully.

Conclusion: A Collaborative Path to Future Success
The 8th Annual Pharma Project & Portfolio Management 2025 was a resounding success, providing attendees with invaluable insights, actionable strategies, and real-world case studies to elevate project and portfolio management. From exploring technological innovations to hands-on learning and collaborative activities, the conference reinforced the industry's commitment to continuous improvement, fostering innovation, and driving organizational success.

With a perfect blend of expert-led presentations, interactive sessions, and networking opportunities, the event reaffirmed its status as a premier gathering for industry professionals dedicated to advancing project and portfolio management.